Alcohol News and Research

RSS

Better targeted, more cost-effective osteoporosis treatment could soon be a reality worldwide

A new method for determining more accurately at which point someone needs further diagnostic tests, or when immediate treatment is warranted, has been developed by The National Osteoporosis Guideline Group in the UK.

3 Dec 2008

New guidelines for neuropathy

New guidelines developed by the American Academy of Neurology find a combination of blood tests and other specialized assessments appear to be the most helpful tests for finding the cause of neuropathy.

3 Dec 2008

Brains of low-income children function differently from brains of high-income kids

University of California, Berkeley, researchers have shown for the first time that the brains of low-income children function differently from the brains of high-income kids.

3 Dec 2008

Two alcoholic drinks per day not linked with higher risk of atrial fibrillation for women

Women who have up to two alcoholic drinks per day do not appear to be at increased risk of atrial fibrillation (irregular heart beat), but drinking more than that amount is associated with a higher risk, according to a study in the December 3 issue of JAMA, the Journal of the American Medical Association.

3 Dec 2008

Worrying about your health? more government money will help you stay well

A national poll by the Australian medical research body, Research Australia, has found that many Australians are worried about developing a range of chronic diseases during their lifetime, particularly diseases such as arthritis.

2 Dec 2008

Psychiatric disorders common among 18 to 24-year-olds

Psychiatric disorders appear to be common among 18 to 24-year-olds, with overall rates similar among those attending or not attending college, according to a report in the December issue of Archives of General Psychiatry.

1 Dec 2008

Babies exposed to tobacco in utero more irritable, difficult to soothe

Previous studies have shown that babies exposed to tobacco in utero are more likely to have a low birth weight and are at increased risk for sudden infant death syndrome.

1 Dec 2008

Scientists discover new properties of imidazolium salts

Scientists at Singapore's Institute of Bioengineering and Nanotechnology (IBN) have uncovered new properties of imidazolium salts (IMSs), which suggest that they could play a vital role in disease prevention and treatment.

1 Dec 2008

Etanercept found to be ineffective in treating alcoholic hepatitis

A new study from Mayo Clinic finds the use of the drug therapy etanercept ineffective in treating alcoholic hepatitis, an acute inflammation of the liver caused by excessive consumption of alcohol. The results of the study are published in the December issue of Gastroenterology.

1 Dec 2008

Alcohol-dependence study looks at impact of pharmacotherapy on quality-of-life

Most studies examining the impact of alcohol-dependence (AD) treatment on quality-of-life (QOL) have looked at psychosocial treatments.

1 Dec 2008

Bariatric surgery may resolve liver disease

Obesity is a growing epidemic in the U.S. with a significant increase in prevalence from 15 percent to 32.9 percent from 1980 to 2004. Nonalcoholic fatty liver disease (NAFLD) is an emerging problem related to the obesity epidemic, becoming one of the most common causes of liver disease in the nation.

1 Dec 2008

Early alcohol use leads to tolerance to high doses of alcohol later in life

A Baylor University study has found that exposure during adolescence to moderate doses of alcohol in a binge-like fashion does in fact produce tolerance to high doses of alcohol later in life.

1 Dec 2008

Liver disease tackled with dedicated unit at Imperial College London

Liver disease death rates are rising in the UK, in contrast to other common diseases such as heart disease and cancer, and the new Robert Hesketh Hepatology Clinical Research Facility aims to provide care and develop new therapies to reverse this trend.

1 Dec 2008

Eli Lilly withdraws application for additional U.S. indication for Cymbalta for chronic pain

Eli Lilly and Company has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug Administration (FDA) for Cymbalta (duloxetine HCl) for the management of chronic pain.

30 Nov 2008

Schoolies warned that after-effects of drinking or drug-taking could disguise the start of meningococcal disease

Following reports that an 18-year-old student celebrating 'schoolies' week on Queensland's Gold Coast has been hospitalised with meningococcal disease, health officials have warned schoolies that the after-effects of drinking or drug-taking could disguise the onset of the disease.

26 Nov 2008

Trends in sexual risk behaviors, by nonsexual risk behavior involvement, U.S. high school students

Although teens who engage in risky health behaviors such as smoking and drunk driving are likelier to participate in sexual activity than more cautious peers, interventions aimed at reducing sexual activity appear to be similarly effective in high-risk and low-risk teens, a new study finds.

25 Nov 2008

Increase in adoption of children in care in Northern Ireland

The number of children being adopted from care in Northern Ireland has increased, according to a study by Queen's University. However, Health Boards and Trusts vary dramatically in their decisions on long-term placements for children in care.

25 Nov 2008

King Pharmaceuticals and Alpharma sign definitive merger agreement

King Pharmaceuticals, Inc. and Alpharma Inc. have announced that the two companies have signed a definitive merger agreement under which King will acquire all of the outstanding shares of Class A Common Stock of Alpharma for $37.00 per share in cash for a total equity value of approximately $1.6 billion.

24 Nov 2008

Health study in northern Uganda calls for improved services for internally displaced persons

There are over 1 million internally displaced persons (IDPs) in Uganda due to the 20-year conflict waged between a rebel group, the Lord's Resistance Army, and the central government.

24 Nov 2008

Tapentadol hydrochloride approved for pain relief

The U.S. Food and Drug Administration has approved Tapentadol hydrochloride, an immediate-release oral tablet for the relief of moderate to severe acute pain.

24 Nov 2008